MediPal Holdings Corporation

7459.T
Medical Distribution
2026/10/23 10:54 Updated
Market Cap: $4.2B (¥658.5B)
Stock Price: $20.49 (¥3,217)
Exchange Rate: 1 USD = ¥156.99

Notice of Revision to Full-Year Consolidated Earnings Forecast

Revised the full-year consolidated earnings forecast for the fiscal year ending March 2027. Net sales of 3,944,000 hundred million yen remain unchanged from the previous forecast, operating income and ordinary income remain unchanged, net income attributable to owners of parent increased from 43,000 hundred million yen to 53,000 hundred million yen, and basic earnings per share revised upward from 210.06 yen to 258.92 yen. The primary reason is the expected recognition of special gains due to the sale of investment securities.

Importance:
Page Updated: October 23, 2026
IR Disclosure Date: October 23, 2026

Key Figures

  • Net Sales: 3,944,000 hundred million yen
  • Net Income Attributable to Owners of Parent: 53,000 million yen
  • Basic Earnings Per Share: 258.92 yen

AI要約

Summary of Forecast Revision

In today's announced revision to the full-year consolidated earnings forecast, net sales, operating income and ordinary income remain unchanged from the previous forecast, while net income attributable to owners of parent and basic earnings per share were revised upward. The primary reason is the expected increase in net income due to the recognition of gains on sale of investment securities (special gains) and the impact of reducing strategic investment holdings.

Outlook and Cautionary Notes

The consolidated earnings forecast is based on information available as of the announcement date, and actual results may differ depending on future developments. Investors should note that one-time factors such as the recognition of special gains may affect results.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

MediPal Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →